Is the reactive oxygen species-dependent-NF-κB activation observed in iron-loaded BALB/c mice a key process preventing growth of Leishmania major progeny and tissue-damage?

Microbes and Infection

Volumn 8, Issue 6, 2006, Pages 1473-1482

  Bisti, Sylvia ^a   Soteriadou, Ketty ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Iron; Leishmania major; NF B activation; Protection status; Re infection; Resistance; ROS

Indexed keywords

DIPHENYLIODONIUM SALT; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON DEXTRAN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL POPULATION; CHRONOTHERAPY; CONTROLLED STUDY; EAR; FEMALE; IMMUNITY; INFECTION PREVENTION; INFECTION RESISTANCE; INOCULATION; INTRACELLULAR SPACE; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; PROGENY; PROMASTIGOTE; RESPIRATORY BURST; SENSITIVITY ANALYSIS; T LYMPHOCYTE; TISSUE INJURY; UPREGULATION;

ANIMALS; ANTIOXIDANTS; CD4-POSITIVE T-LYMPHOCYTES; EAR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOCYTOCHEMISTRY; INTERFERON TYPE II; IRON-DEXTRAN COMPLEX; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NF-KAPPA B; ONIUM COMPOUNDS; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; SPECIFIC PATHOGEN-FREE ORGANISMS;

LEISHMANIA MAJOR;

EID: 33745162955     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.01.004     Document Type: Article

References (28)

1. Reiner S.L., and Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13 (1995) 151
2. Belosevic M., Finbloom D.S., Van Der Meide P.H., Slayter M.V., and Nacy C.A. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143 (1989) 266
3. Liew F.Y., Millott S., Parkinson C., Palmer R.M., and Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l-arginine. J. Immunol. 144 (1990) 4794
4. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., and Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375 (1995) 408
5. Heinzel F.P., Sadick M.D., Mutha S.S., and Locksley R.M. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7011
6. Sypek J.P., Chung C.L., Mayor S.E., Subramanyam J.M., Goldman S.J., Sieburth D.S., Wolf S.F., and Schaub R.G. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177 (1993) 1797
7. Stenger S., Thuring H., Rollinghoff M., and Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180 (1994) 783
8. Shapira S., Speirs K., Gerstein A., Caamano J., and Hunter C.A. Suppression of NF-kappaB activation by infection with Toxoplasma gondii. J. Infect. Dis. 185 Suppl 1 (2002) S66
9. Mason N.J., Artis D., and Hunter C.A. New lessons from old pathogens: what parasitic infections have taught us about the role of nuclear factor-kappaB in the regulation of immunity. Immunol. Rev. 201 (2004) 48
10. Artis D., Speirs K., Joyce K., Goldschmidt M., Caamano J., Hunter C.A., and Scott P. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major. J. Immunol. 170 (2003) 1995
11. Bisti S., Konidou G., Papageorgiou F., Milon G., Boelaert J.R., and Soteriadou K. The outcome of Leishmania major experimental infection in BALB/c mice can be modulated by exogenously delivered iron. Eur. J. Immunol. 30 (2000) 3732
12. Sacks D.L., and Perkins P.V. Development of infective stage Leishmania promastigotes within phlebotomine sand flies. Am. J. Trop. Med. Hyg. 34 (1985) 456
13. Titus R.G., Marchand M., Boon T., and Louis J.A. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7 (1985) 545
14. Leclercq V., Lebastard M., Belkaid Y., Louis J., and Milon G. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. J. Immunol. 157 (1996) 4537
15. Lyons A.B., and Parish C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171 (1994) 131
16. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59 (2000) 13
17. Bird J.J., Brown D.R., Mullen A.C., Moskowitz N.H., Mahowald M.A., Sider J.R., Gajewski T.F., Wang C.R., and Reiner S.L. Helper T cell differentiation is controlled by the cell cycle. Immunity 9 (1998) 229
18. Grogan J.L., Mohrs M., Harmon B., Lacy D.A., Sedat J.W., and Locksley R.M. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14 (2001) 205
19. May M.J., and Ghosh S. Signal transduction through NF-kappa B. Immunol. Today 19 (1998) 80
20. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621
21. Sha W.C. Regulation of immune responses by NF-kappa B/Rel transcription factor. J. Exp. Med. 187 (1998) 143
22. Baeuerle P.A., and Baltimore D. NF-kappa B: ten years after. Cell 87 (1996) 13
23. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12 (1994) 141
24. Baeuerle P.A., Rupec R.A., and Pahl H.L. Reactive oxygen intermediates as second messengers of a general pathogen response. Pathol. Biol. (Paris) 44 (1996) 29
25. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225
26. Prive C., and Descoteaux A. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur. J. Immunol. 30 (2000) 2235
27. Ghosh S., Bhattacharyya S., Sirkar M., Sa G.S., Das T., Majumdar D., Roy S., and Majumdar S. Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase. Infect. Immun. 70 (2002) 6828
28. Cameron P., McGachy A., Anderson M., Paul A., Coombs G.H., Mottram J.C., Alexander J., and Plevin R. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J. Immunol. 173 (2004) 3297